Description
A potent and selective agonist for the EP4 receptor (Ki = 0.7, 56, 620, and >10,000 nM for EP4, EP3, EP2, and EP1, respectively); promotes EP4-mediated bone formation, prevention of bone loss related to osteoporosis, osteoblast differentiation, and the stabilization of bone implants; supports wound healing
Formal name: 4-[[2R-[3R-hydroxy-2-[3S-hydroxy-4-[3-(methoxymethyl)phenyl]-1R-buten-1E-yl]-5-oxocyclopentyl]ethyl]thio]-butanoic acid, methyl ester
Synonyms: ONO-4819
Molecular weight: 450.6
CAS: 256382-08-8
Purity: ≥98%
Formulation: A solution in methyl acetate
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Endocrinology & Metabolism|Bone Growth & Remodeling||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway